Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)
The mpox 2022 outbreak was declared a public health emergency in July 2022. In August 2022, the MVA–BN vaccine received emergency use authorization in the United States (US) to target at-risk groups. This study (EUPAS104386) used HealthVerity’s administrative US healthcare data to generate real-worl...
Gardado en:
| Principais autores: | , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI AG
2024-06-01
|
| Series: | Vaccines |
| Assuntos: | |
| Acceso en liña: | https://www.mdpi.com/2076-393X/12/6/651 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|